Loading clinical trials...
Loading clinical trials...
The purpose of the study is to determine the safety and efficacy of high and low strength of ME1111 solutions compared to the vehicle in the treatment of onychomycosis of the toenail.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Meiji Seika Pharma Co., Ltd.
NCT06485505 · Onychomycosis
NCT06689852 · Onychomycosis
NCT00233493 · Onychomycosis, Tinea Pedis
NCT06175013 · Onychomycosis
NCT06254027 · Onychomycosis
Birmingham, Alabama
Encinitas, California
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions